Get notified when RLAY files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts

Red Flags Detected

  • Holdings of Our Executive Officers, Directors, Principal Stockholders and Their Affiliates, Represented Beneficial Ownership, In the Aggregate, of Approximately 51.2 % of Our Outstanding Common Stock (new) — Insider ownership concentration exceeds 50%, giving insiders majority voting control and the ability to determine corporate actions without public shareholder approval.
  • An Immediate Dilution In As Adjusted Net Tangible Book Value of $7.76 Per Share to New Investors In This Offering (new) — New investors pay $12.00 per share but receive only $4.24 in net tangible book value, an immediate dilution of $7.76 per share (64.7% of the offer price).
NASDAQ: RLAY Relay Therapeutics, Inc. 424B5

Relay Therapeutics prices 22.9M share offering at $12.00, raising $258M net for R&D

Filed May 21, 2026 · ~1 min read

Key Changes

  • high

    Relay Therapeutics is selling 22,916,667 shares at $12.00 per share, with gross proceeds of $275.0M and net proceeds to the company of $258M.

    The Offering verify on EDGAR →
  • medium

    The company intends to use net proceeds for research and clinical development of pipeline candidates, working capital, capital expenditures, and general corporate purposes.

    Use of Proceeds verify on EDGAR →
  • high

    New investors will incur immediate dilution of $7.76 per share, as the as-adjusted net tangible book value after the offering is $4.24 per share.

    Dilution verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (FUL 10-Q) is open in full — no account needed.

Partner

Trade RLAY commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov

Figures/quotes linked to EDGAR · Narrative written by AI · Sep 2, 2026 · How we verify